Astra Zeneca has announced a new travel advisory to patients, advising them to use their own travel documents.
The company has not yet disclosed the exact nature of the advisory, but the move comes after several high-profile medical errors and accidents in the past week.
Astra has previously warned patients about the dangers of using travel documents, which can lead to them being detained at airports or in other locations where they may be refused service.
The advisory states: Astra recommends that patients who are unable to provide their travel documents to a doctor to verify their identity and to verify that they are not travelling on a fraudulent basis or as a member of a terrorist group, should use one of the following documents: Passport or travel document issued by a foreign government, state or local government, or organization that is recognized by the foreign government or state or the organization as being valid for travel to or from the United States.
Any other document that indicates the individual’s identity and eligibility for a specific type of travel or travel benefits.
Any of the above.
These documents may be obtained by contacting the airline or travel agent.
This is the first time Astra said that its patients should use their passports and travel documents as their primary source of travel.
This comes on the heels of reports that Astra was the first large pharmaceutical company to suspend or remove some of its employees over a rash of medical errors, including an asthmatic patient who died after ingesting the wrong medication.
Astramax has also announced that its pharmacy has been working with the Centers for Medicare and Medicaid Services (CMS) to offer a new program to help prevent medical errors at pharmacies.
The pharmacy will be offering a program that will offer free prescription drug cards to pharmacy employees, and a new pharmacy credit card for employees to use for purchasing prescription drugs.
The new pharmacy card is expected to go live on Oct. 14, and the company is asking customers to sign up for the program.
The Astra travel advisory is just the latest in a string of events that has impacted Astra.
On Thursday, the company announced that it would be suspending its participation in the Medicare Part D program.
As part of the program, Medicare Part A patients can receive prescription drugs free of charge through an electronic health record (EHR) system at participating pharmacies, which is currently the only option for Medicare Part B patients.
Astrafacts plans to discontinue participation in Part D and has announced plans to start offering new Medicare Part C plans to Medicare Part K patients starting in October.
These plans are designed to help reduce the number of Medicare Part Part C patients on the Medicare rolls and to help address the growing number of drug-related deaths that are occurring among Medicare Part 1 patients.